Walgreens Program Creates Cancer-Specialized Locations March 15, 2017 By Christine Blank How Walgreens is helping pharmacists be more involved than ever in helping cancer patients. New strategies for managing drug spend: RA, Cancer, Hep C March 04, 2017 The proliferation of specialty drugs has prompted new techniques for keeping costs in tow. Six diseases reap benefits of biomarkers, genetic tests March 02, 2017 By Karen Appold Biomarker testing for harmful genetic mutations provides the opportunity to identify at-risk individuals who might benefit from risk modification strategies and/or enhanced disease screening. Express Scripts’ 2016 Drug Trend Report: 7 things to know February 13, 2017 By Tracey Walker Report highlights spending trends in key areas, including specialty medications, oncology, diabetes, and inflammatory conditions. How precision medicine is improving patient lives: Real examples January 29, 2017 By Tracey Walker An expert at the Precision Medicine World Conference shared cancer patient perspectives on the importance of immuno-oncology and breakthrough targeted therapies and how they have extended their lives. Value-based care takes over J.P. Morgan Healthcare Conference 2017 January 23, 2017 By Marc O'Connor Is the drive to value-based care really accelerating? What can be done amidst all of the uncertainty? Expert shares insights from the J.P. Morgan 35th Annual Healthcare Conference. Top challenges in cancer care January 14, 2017 By Tracey Walker Cancer drug costs remain the most critical challenge in care, among other things. Watch list 2017: Top therapeutic areas January 03, 2017 By Mari Edlin Find out about the latest treatment and drug pipeline developments Is a urine-based test the future of cervical cancer screening? December 14, 2016 By Judith M. Orvos ELS A Phase II study examines the efficacy of a urine-based test in screening for cervical cancer. Also, a study looks at whether cost is the reason why some patients do not adhere to breast cancer medications. Family history, genetics play growing role in leukemia screening December 07, 2016 By Bryant Furlow Inherited susceptibilities to leukemias are becoming better understood and have important implications for screening, prevention, genetic counseling, and treatment.